ID   FB5
AC   CVCL_C3VU
DR   Wikidata; Q116048976
RX   PubMed=1438285;
CC   Biotechnology: The monoclonal antibody produced by this hybridoma was used to prepare the humanized ontuxizumab (MORAb-004) therapeutic antibody which was used in clinical trials for the treatment of metastatic melanoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9HCU0; Human CD248.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
RX   PubMed=1438285; DOI=10.1073/pnas.89.22.10832; PMCID=PMC50436;
RA   Rettig W.J., Garin-Chesa P., Healey J.H., Su S.L., Jaffe E.A.,
RA   Old L.J.;
RT   "Identification of endosialin, a cell surface glycoprotein of vascular
RT   endothelial cells in human cancer.";
RL   Proc. Natl. Acad. Sci. U.S.A. 89:10832-10836(1992).
//